Table 1.
Nanoparticle | Biosynthesis | Chemical synthesis | Mean size (nm) |
Shape | In vitro study |
Dose | In vivo study | Dose | Effect | Reference |
---|---|---|---|---|---|---|---|---|---|---|
CO | ✓ | 75 | Spherical | HUVECs | 1.25, 2.5, and 5 µg/mL | Nude mice Matrigel plug | 1.25, 2.5, and 5 µg/mL | Antiangiogenic | 9 | |
Au | ✓ | 15 | Spherical | HUVECs | 125 and 250 nM | CAM | 1,000 and 1,500 nM/egg | Antiangiogenic | 12 | |
Ag | ✓ | 16 | Spherical | – | – | CAM | 50 and 200 µg/mL | Antiangiogenic | 15 | |
Ag | ✓ | 50 | Spherical | BRECs | 500 nM | C57BL/6 mice | 500 nM | Antiangiogenic | 16 | |
Ag | ✓ | 10 | Spherical | HUVECs | 50, 100, 200, and 400 µg/mL | – | – | Antiangiogenic | 17 | |
Au | ✓ | 20 100 |
Spherical Spherical |
HUVECs | 16.60 pM | C57BL/6 mice | 16.60 pM | Antiangiogenic | 18 | |
SiO2 | 20 100 |
Spherical Spherical |
||||||||
TiO2 | ✓ | 20 | Monodisperse | HRMECs | 1.30 µg/mL | C57BL/6 mice | 1.30 µg/mL | Antiangiogenic | 19 | |
Au | ✓ | HUVECs | Antiangiogenic | 20 | ||||||
HAP | ✓ | 20 | Spherical | HUVECs | 50 and 100 µg/mL | – | – | Antiangiogenic | 21 | |
80 | Rod–like | |||||||||
UDD | ✓ | 6 | Ultra dispersal |
– | – | GBM cell on CAM | 200 µ/ML 500 µ/ML |
Antiangiogenic | 22 | |
MW–RF | 65 | Unknown | ||||||||
Au | ✓ | 20 | Unknown | HUVECS | 0.1, 1, and 10 µM | C57BL/6 mice | 10 µM | Antiangiogenic | 23 | |
NCe | ✓ | 20 | Crystal | 5,10, and 20 | Unknown | Nude mice | 0.1 mg/kg | Antiangiogenic | 24 | |
Au | ✓ | 20 | Unknown | HRMECs | 1 and 5 µM | C57BL/6 mice | 1 µM | Antiangiogenic | 25 | |
SiNPs | ✓ | 57 | Spherical | HRMECs, | 5 µg/mL | C57BL/6 mice | 10 µg/mL | Antiangiogenic | 26 | |
Ag | ✓ | 13 | Spherical | – | – | Rat aortic ring model | 200 and 300 µg/mL | Antiangiogenic | 27 | |
ZnO | ✓ | 20 | Spherical | – | – | CAM | 50 µg/mL | Antiangiogenic | 28 | |
Au | ✓ | 14 | Monodisperse | – | – | CAM Mouse, Matrigel model |
1 µg/cam 10 µg/Matrigel |
Antiangiogenic | 29 | |
Ag | 20 | Polydisperse | ||||||||
CNPs | ✓ | 63 | Unknown | – | – | Athymic Nude mice | 60 and 90 mg/kg | Antiangiogenic | 30 | |
ND | 4 | Spherical | – | – | CAM | 500 mg/L | Antiangiogenic | 31 | ||
MWNT | 8 | Nanotube | Antiangiogenic | |||||||
NG | 4 | Spherical | No effect | |||||||
GNS | 7 | Sheet | No effect | |||||||
C60 | ✓ | 50 | Spherical | Angiogenic | ||||||
Ag | ✓ | 50 | Unknown | BRECs | 500 nM | – | – | Antiangiogenic | 32 | |
Diamond | ✓ | 4 | Unknown | – | – | GBM cell on CAM | 50 µg/mL | Antiangiogenic | 33 | |
SiO2 | ✓ | 25 | Unknown | HUVECs | 2.5 nM | No effect | 34 |
Abbreviations: CAM, chorioallantoic membrane; HUVECs, human umbilical vein endothelial cells; BRECs, bioartificial renal epithelial cells; HAP, Hydroxyapatite; UDD, ultra dispersed detonation diamond; MW-RF, micowave-radiofrequency; NCe, nanoceria; SiNPs, silicate nanoparticles; GBM, glioblastoma; CNPs, chitosan nanoparticles; DN, diamond nanoparticle; MWNT, multiwall nanotubes; NG, graphite nanoparticles; GNS, graphene nanoparticles; C60, fullerenes nanoparticles.